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Mass spectrometric structural analysis of crosslinked peptides is a powerful method to
elucidate the spatial arrangement of polypeptides in protein complexes. Our aim is to develop
bifunctional crosslinkers that, after crosslinking protein complexes followed by proteolytic
digestion, give rise to crosslinked peptides that can be readily tracked down by mass
spectrometry. To this end we synthesized the crosslinker N-benzyliminodiacetoyloxysuc-
cinimid (BID), which yields stable benzyl cation marker ions upon low-energy collision-
induced dissociation (CID) tandem mass spectrometry. Sensitive detection of the marker ion
upon low-energy CID is demonstrated with different BID-crosslinked peptide preparations.
With BID it becomes possible to retrieve crosslinked and crosslinker-adducted peptides,
without the necessity of purifying crosslinked peptides prior to identification. The basic design
of this crosslinker can be varied upon, in order to meet specific crosslinking needs. (J Am Soc
Mass Spectrom 2001, 12, 222–227) © 2001 American Society for Mass Spectrometry
Many proteins carry out their functions as partof multisubunit complexes. These complexesare assembled into unique quaternary struc-
tures, either transiently as assembly intermediates or as
fully functional molecular machines. Knowledge about
the identity of the composing subunits and their spatial
arrangement is crucial for understanding the functional
organization of such biological assemblies.
Mass spectrometry is already widely used to identify
the components of multisubunit complexes [1], and is
gaining importance as a tool to investigate spatial and
topological relationships. Among the methods used are
hydrogen–deuterium exchange to monitor solvent ac-
cessibility [2], direct ionization and desorption of com-
plexes to detect noncovalent interactions [3, 4], and the
use of chemical crosslinking followed by digestion and
mass spectrometric identification of the crosslinked
components [5–8]. Aside from information on the rela-
tive topological organization of its constituents, a
crosslinked complex could also reveal data on the exact
orientation of these subunits. By identifying the resi-
dues involved in a crosslink, it becomes possible to map
the interacting surfaces of the proteins. Combining this
with structural data from other sources (NMR, X ray,
electron microscopy) an integrated view on the cellular
molecular machinery can be constructed.
Despite the apparent straightforwardness of the
crosslink approach, reports of successful applications
have been scarce [7–9]. The detection of crosslinked
peptides with mass spectrometric techniques has
proven to be difficult, for which several explanations
could be advanced. A crosslinked peptide will on
average be larger than unmodified counterparts, ham-
pering ionization due to suppression effects. More
importantly, the crosslinking reaction is directed
against functional groups on amino acid side chains
that are omnipresent in protein molecules. To increase
the specificity of the crosslinking reaction, and to avoid
linking together all the components present in a com-
plex, reaction conditions are to be kept relatively mild
[5, 10]. This, however, results in incomplete crosslinking
and partial adduction of crosslinker molecules to side
chains of the protein while not participating in a
crosslink. Hence the peptide population resulting from
a digest of properly crosslinked complexes will be
heterogeneous, and the signal corresponding to the
same part of the protein will be divided over several
peaks.
To overcome these problems different strategies
have been employed. A potentially powerful approach
is the use of a crosslinker that allows purification or
selective monitoring during purification. Chen et al. [11,
12] have devised a method to derivatize a crosslinked
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reaction product, making use of the fact that a
crosslinked peptide contains two free aminotermini.
In this paper we describe the synthesis of the
crosslinker N-benzyliminodiacetoyloxysuccinimid (BID)
(Figure 1). This crosslinker allows the specific retrieval
of crosslinked peptides using mass spectrometric tech-
niques. It contains a spacer chain that yields benzyl
cations as an ionic marker upon selection and fragmen-
tation. The marker ions can be easily detected by both
triple quadrupole and hybrid quadrupole time-of-flight
mass spectrometers, the most widely used detectors for
structure elucidation of peptides and peptide deriva-
tives.
This structure can in principle be combined with
different reactivities towards functional groups of pro-
teins, see [10] for details. In this instance we used bis
N-hydroxysuccinimidyl esters, that react rapidly and
specifically with primary amines such as lysine side
chains and free N-termini through nucleophilic substi-
tution.
We present the results of its application to two model
peptides, tyrlysbradykinin (YKB) and neurotensin.
These peptides mimic the situation after digestion of a
crosslinked protein in which one will find both intra-
chain crosslinked and interchain crosslinked peptides.
Methods
Mass Spectrometry
Reaction products were analyzed on a Micromass Q-
TOF (Micromass, Whyttenshawe, UK) mass spectrom-
eter equipped with a Z-spray nanoelectrospray source,
using gold coated nanoelectrospray capillaries (Pro-
tana, Odense, Danmark). Capillary voltage was in the
range of 650 to 900 V. Cone voltage was set to 40 V in all
experiments. Low-energy collision-induced dissocia-
tion (CID) experiments were performed using argon as
a collision gas in the collision hexapole at a pressure of
3.4 3 1025 mbar as measured on the selection quadru-
pole ion gauge.
NMR
1H NMR spectroscopy in D-DMSO (dimethyl sulfox-
ide) was performed with a Varian 500 NMR spectrom-
eter.
Synthesis of BID
All chemicals were purchased from Aldrich (Milwau-
kee, WI) and used without further purification. BID was
synthesized analogous to other N-hydroxysuccimid es-
ters [13, 14]; to a closed 10 mL reaction vessel containing
a solution of 223 mg (1 mmol) N-benzyliminodiacetic
acid and 230 mg (2 mmol) N-hydroxysuccinimid in 4
mL dry dimethylformamide (DMF) was added a solu-
tion of 460 mg (2.2 mmol) dicyclohexylcarbodiimide in
1 mL dry DMF. The reaction solution was stirred
overnight at 20 °C. The dicyclohexylurea precipitate
was removed by filtration and the solution was evapo-
rated to near dryness. The product was solubilized in
dry ether from which 300 mg crystallized as a pure
product. The yield was 72%. For nanoelectrospray mass
spectrometry, BID was dissolved in acetonitrile:formic
acid 99:1 v/v to a concentration of 10 mM.
Synthesis of Ring-Closed Tyrlysbradykinin and
Crosslinked Neurotensin
Neurotensin and tyrlysbradykinin were purchased
from Novabiochem (La¨ufelfingen, Switzerland) and
used without further purification. Peptides were dis-
solved in dry DMF to a concentration of 6 mM. To this
solution was added a solution of 30 mM BID in DMF to
a final concentration of 3 mM. After 30 min a 20-fold
excess of water was added to hydrolyze the unreacted
N-hydroxysuccinimide groups. From this solution the
product was collected and cleaned on a ZipTip C18
micropipettetip (Millipore, Bedford) according to the
manufacturers instructions and eluted and further di-
luted in a solution of methanol:water:formic acid 60:
36:4 v/v for nanoelectrospray.
Results and Discussion
Design of the Crosslinker
A crosslinker yielding fragments that can be detected in
MSMS experiments has to conform to a number of
prerequisites: (i) the site of fragmentation must have a
high proton affinity to allow fragmentation in low-
energy CID, (ii) the ionic marker must be a stable
leaving group, and (iii) the energy required for frag-
mentation should be comparable to the amount of
energy required for fragmenting peptides, preferen-
tially somewhat lower.
For the leaving group we chose a benzyl group,
which forms stable cations that can be detected at m/z
91. The fragmentation reaction predicted from a mole-
cule with a crosslink formed between the primary
amines of two lysine side chains is outlined in Figure 2.
The attachment of the leaving group to the spacer chain
is through a tertiary amine, giving a proton affinity of
approximately 968.4 kJ/mol (based on the proton affin-
ity of N,N-dimethyl-benzylamine) [15], which in pro-
teins is only surpassed by those of the side chains of
Figure 1. Structure of the crosslinker N-benzyliminodiacetoylhy-
droxysuccinimid (BID).
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arginine (1051.0 kJ/mol), lysine (996.0 kJ/mol), and
histidine (988.0 kJ/mol) [15].
Characterization of BID
Nanoelectrospray mass spectrometry and MSMS of BID
(data not shown) was performed as described in meth-
ods. We observed the singly charged ion at m/z 418.1.
This ion was selected for fragmentation, yielding frag-
ment ions consistent with the structure. One of the two
major observed fragment ions is at m/z 91, a benzyl
cation formed as a result of protonation on the tertiary
amine in the spacer chain with direct loss of the leaving
group. The other major product ion at m/z 275.1 was
identified as an imonium ion.
1H NMR at 500 MHz in D-DMSO yielded the
following: 7.3/7.4 ppm(m,5H), 3.97 ppm(s,4H), 3.87
ppm(s,2H), and at 2.86 ppm(2,8H). These findings are
consistent with the inferred structure.
Ring Closed Tyrlysbradykinin
Crosslinking of YKB was performed as described in
Methods. Expected products from the reaction of YKB
with BID would include a ring-closed structure, where
the succinimidyl groups of the crosslinker have reacted
with the primary amine present on the N-terminus of
the peptide and the primary amine of the side chain of
the lysine residue at position two [10] (shown in Figure
3), as well as adducted peptides. Under the conditions
used, ring closure is the most likely phenomenon. Once
a crosslinker has reacted with one of the available
amino groups, the proximity of the other amino group
in the same molecule will make a reaction with the
second reactive N-succinimidyl group highly likely.
Adducted peptides, where one reactive end of the
crosslinker has formed an amide bond to one of the
primary amines and the other succinimidyl moiety is
hydrolyzed upon termination of the reaction are de-
tected in minor amounts only (data not shown).
In nanoelectrospray mass spectrometry the ions of
ring-closed YKB are found both doubly and triply
protonated at m/z 769.87 and 513.59, respectively. The
ions were further characterized by MSMS, yielding
fragments consistent with the structure. Most impor-
tantly, fragment ions at m/z 607.3 and 635.3 were
identified as a and b ions stemming from cleavage of
the peptide bond between lysine and arginine, proving
the linkage of the N-terminus to the lysine. Neutral loss
of CO further confirmed the inferred closed ring [16].
In Figure 4 the MSMS spectra of the doubly and
triply protonated ions of YKB-BID are compared at
threshold energy required for fragmentation. For the
31 ion the predicted loss of a benzyl cation is indeed
the primary fragmentation pathway, occurring at a
threshold Elab (5zVcoll) of 45 eV. This suggests the third
proton is predominantly localized at the amine in the
spacer chain, and the reaction channel for loss of a
benzyl cation is favorable at low collisional activation.
At higher collisional energies more extensive fragmen-
tation, also along the peptide backbone, is observed.
From the 21 ion, with a threshold Elab for fragmenta-
tion of 60 eV, the initial daughter ions formed are the
y01 and the y08 ion, together with the accompanying b4
ion. This corresponds to fragmentation adjacent to the
arginine residues at position 3 and 11, respectively. As
has been noted previously, arginine tends to lock the
protons, resulting in selective cleavage along the most
favorable pathway [17]. Threshold Elab for the forma-
tion of a benzyl cation from doubly protonated YKB is
70 eV, but this process is less efficient than benzyl cation
formation from the triply protonated parent. In addi-
tion, it should be noted that at higher collisional activa-
tion the triply charged species of crosslinked YKB also
yields more informative sequence ions than does the
doubly charged molecule (data not shown), in agree-
ment with the results of Tsaprailis et al. [17, 18].
Crosslinked Neurotensin
Crosslinking of neurotensin was done as described in
Methods. Neurotensin contains only one primary
amine on the side chain of lysine at position six. Under
the conditions used, this group is the only available
reactive group toward the N-succinimidyl-esters.
Therefore a crosslinked product, as depicted in Figure
5, is the expected outcome, aside from a hydrolyzed
Figure 2. Proposed mechanism for the formation of benzyl
cations from a crosslinked peptide molecule.
Figure 3. Structure of BID-ring-closed tyrlysbradykinin (YKB-
BID). The ring-closed peptide was synthesized as described in
methods and characterized by low-energy CID MSMS. The struc-
ture of the residues involved in the crosslink have been fully
drawn, the rest of the amino acids are abbreviated using single
letter code.
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side product which is formed when the reaction is
quenched with water. The expected monoisotopic mo-
lecular mass of this ion is 3530.88, which we observed in
the 31, 41, and 51 charge state. Further characteriza-
tion was performed with low-energy CID, yielding
sequence ions consistent with the inferred structure. A
summary of the most important fragments observed are
indicated in Figure 5. The CID spectrum of the 51 ion
recorded at an Elab of 100 eV is shown in Figure 6.
The fivefold protonated molecule also yields m/z 91
and the complementary ion (at m/z 861; z 5 4) much
more efficiently than the lower charge species. From
Figure 7 it can be seen that this loss starts as a significant
process for the 51 form at an Elab of 87.5 eV, while the
fourfold protonated ion requires an Elab of at least 140
eV. The triply protonated species gives off benzyl
cations only poorly at an Elab of approximately 180 eV.
Because of the low ion current during those experi-
ments, the data on the 31 ion have not been plotted in
Figure 7.
Protonation of BID crosslinked neurotensin results in
the first four charges being apparently locked on side
chains of the peptide chain. The extra charging pro-
ton—in this case the fifth—can be thought to be local-
ized in the spacer chain amine. Once this amine is
protonated, fragmentation of the bond between the
nitrogen and the benzyl moiety is the most energetically
favorable process. Indications for cleavage of the other
Figure 4. Fragmentation of BID-ring-closed tyrlysbradykinin. The peptide was crosslinked as
described in Methods. Low-energy CID spectra at threshold collisional activation reveal the most
favorable fragmentations. Upper panel: charge state 21, at Elab 5 60 eV the first fragments observed
are y01 (m/z 175.1; z 5 1), y08 (m/z 904.2; z 5 1), and b4 (m/z 635.2; z 5 1), corresponding to cleavage
adjacent to the two arginine residues in the molecule. These arginine residues are thought to lock the
protons, causing preferential fragmentation. Lower panel: charge state 31, at Elab 5 45 eV. Ready loss
of benzyl cations is seen at m/z 91 and the complementary ion at m/z 724.8; z 5 2. The signal at m/z
504.2; z 5 3 can be attributed to neutral loss of CO, the signal at m/z 449.8; z 5 3 corresponds to the
neutral loss of tyrosynyl plus CO (see Figure 3).
Figure 5. Structure of BID-crosslinked neurotensin. The mole-
cule was prepared as described in Methods. The crosslinked lysine
residues and the spacer chain have been fully drawn, the rest of
the amino acids are abbreviated using single letter code, Z denotes
pyroglutamate. Indicated are the observed b or y0 ions in CID
MSMS at an Elab of 100 eV used for structural confirmation
(spectrum shown in Figure 6). The main fragmentation process in
the crosslinker chain is the formation of benzyl cations (m/z 91)
and the complementary ion at m/z 861.4; z 5 4. A side process,
cleavage of the amide bond in the crosslinker chain, is accompa-
nied by CO loss, forming an imonium ion detected at m/z 611.3;
z 5 3. The loss of a benzyl cation from this imonium ion yields the
ion at m/z 871.2; z 5 2.
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bonds to the tertiary amine are not observed. We do
observe fragment ions stemming from cleavage of the
amide bonds introduced by the crosslinker. These frag-
ments are also indicated in Figure 4. Interestingly, we
do not detect an acylium (or oxazolonium) “b-type” ion
[19]. It seems that cleavage of the amide bond in the
crosslinker chain is accompanied by concerted CO loss
[20], forming an imonium ion detected at m/z 611.3
(31). This ion can subsequently give off a benzyl cation
and is then detected at m/z 871.2 (21). This is illustrated
in Figure 5.
As a side product of the crosslinking reaction of
neurotensin a minor portion of the peptide bound to the
crosslinker in which the other reactive end was hydro-
lyzed is also found in minor amounts (M 5 1876.98),
both as a doubly and triply charged species (data not
shown). This conjugated neurotensin also gives off a
benzyl cation more efficiently from the more highly
charged precursor ions. For the triply charged peptide
this process has a threshold Elab of 60 eV, whereas for
the doubly charged ion the threshold Elab is approxi-
mately 100 eV (data not shown).
Conclusion
The crosslinker BID has been successfully applied to
crosslink primary amines present in peptide and pro-
tein chains. The presence of a tertiary amine with the
attached benzyl side chain in the spacer chain does not
affect the crosslinking capabilities of N-hydroxysuccin-
imidyl-esters. Low-energy CID MSMS of crosslinked
molecules did release the marker benzyl cation, thus
making the identification of crosslinker-containing ions
straightforward. Under appropriate conditions the ben-
zyl cation was even the most abundant CID generated
ion. This will allow a rapid screen of all potentially
informative ions in a complex mixture of crosslinked
peptides by parent ion scanning.
Crosslinking has always been a trial and error pro-
cess for a particular protein complex [5, 10], and several
crosslinkers are to be tested before a desired crosslink
can be observed. The basic design which we presented
here can be varied upon, either by lengthening the
spacer chain with methylene groups to give the
crosslinker more “reach,” or by adding different reac-
tive groups to extend the reactivity towards other
functional groups present in polypeptides.
A possibility to quaternarize the amine in the linker
chain and thus fix the charge next to the desired leaving
group could also be considered. The advantage would
be that all charge states of a crosslinked peptide would
have a reaction channel that does not require proton
shuffling for yielding marker ions.
The benzyl label is easily detectable in low-energy
CID experiments. Therefore crosslinkers like BID can be
used to easily retrieve sites of attachment between
peptide chains by parent-ion scanning peptide mixtures
derived from the digestion of crosslinked protein com-
plexes.
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